The need for investigations to elucidate causes and effects of abnormal uterine bleeding

Seminars in Reproductive Medicine

Volumn 29, Issue 5, 2011, Pages 410-422

  Munro, Malcolm G ^a   Heikinheimo, Oskari ^b   Haththotuwa, Rohana ^c   Tank, Jaydeep D ^d   Fraser, Ian S ^e  

^a KAISER PERMANENTE   (United States)

^b UNIVERSITY OF HELSINKI   (Finland)

^c Baby Hospital   (Sri Lanka)

^d Ashwini Maternity and Surgical Hospital   (India)

^e UNIVERSITY OF SYDNEY   (Australia)

Author keywords

Abnormal uterine bleeding; heavy bleeding; imaging; investigations

Indexed keywords

ALKALINE HEMATIN; HEMOGLOBIN; REAGENT; UNCLASSIFIED DRUG;

ABNORMAL UTERINE BLEEDING; ADENOMYOSIS; ANEMIA; ARTICLE; BLEEDING; BLOOD CELL COUNT; BLOOD CLOTTING DISORDER; BLOOD EXAMINATION; CLINICAL EVALUATION; COMORBIDITY; COMPARATIVE STUDY; CULTURAL FACTOR; DIAGNOSTIC IMAGING; DIAGNOSTIC TEST; DISEASE CLASSIFICATION; ENDOMETRIAL DISEASE; ENDOMETRIAL ECHO COMPLEX; ENDOMETRIUM BIOPSY; ENDOMETRIUM POLYP; FEMALE; FOLLOW UP; GYNECOLOGICAL EXAMINATION; HEALTH CARE; HEMATOCRIT; HISTOPATHOLOGY; HUMAN; HYPERPLASIA; HYSTEROSCOPY; IATROGENIC DISEASE; LABORATORY TEST; LEIOMYOMA; MENSTRUATION DISORDER; MYOMETRIUM; NUCLEAR MAGNETIC RESONANCE IMAGING; OVARY INSUFFICIENCY; PATHOPHYSIOLOGY; PELVIC EXAMINATION; PHYSICAL EXAMINATION; PRACTICE GUIDELINE; QUALITY OF LIFE; RISK ASSESSMENT; SCREENING; SYMPTOM; TRANSVAGINAL ECHOGRAPHY; TREATMENT INDICATION; UTERINE CERVIX CANCER;

DEVELOPING COUNTRIES; DIAGNOSTIC TECHNIQUES, OBSTETRICAL AND GYNECOLOGICAL; FEMALE; HEALTH CARE COSTS; HEALTH SERVICES ACCESSIBILITY; HUMANS; MENSTRUATION; MENSTRUATION DISTURBANCES; PREDICTIVE VALUE OF TESTS; RISK ASSESSMENT; RISK FACTORS; UTERINE HEMORRHAGE; UTERUS; WOMEN'S HEALTH;

EID: 80855164472     PISSN: 15268004     EISSN: 15264564     Source Type: Journal    
DOI: 10.1055/s-0031-1287665     Document Type: Article

References (74)

1. Fraser IS, Critchley HO, Broder M, Munro MG. The FIGO recommendations on terminologies and definitions for normal and abnormal uterine bleeding. Semin Reprod Med 2011 29 5 383-390
2. Munro MG, Critchley HO, Broder MS, Fraser IS, FIGO Working Group on Menstrual Disorders. The FIGO Classification System (PALM-COEIN) for causes of abnormal uterine bleeding in non-gravid women of reproductive age. Int J Gynaecol Obstet 2011 113 3-13
3. Munro MG, Critchley HO, Fraser IS. The flexible FIGO classification concept for underlying causes of abnormal uterine bleeding. Semin Reprod Med 2011 29 5 391-399
4. O'Donovan PJ, Miller CE. Modern Management of Abnormal Uterine Bleeding. London, UK Informa Healthcare 2008
5. Munro MG. Abnormal Uterine Bleeding. Cambridge, UK Cambridge University Press 2010
6. Lieng M, Istre O, Sandvik L, Engh V, Qvigstad E. Clinical effectiveness of transcervical polyp resection in women with endometrial polyps: randomized controlled trial. J Minim Invasive Gynecol 2010 17 3 351-357
7. Matteson K, Munro MG, Fraser IS. The structured menstrual history: developing a tool to facilitate diagnosis and to aid in symptom management. Semin Reprod Med 2011 29 5 423-435
8. Santer M, Wyke S, Warner P. What aspects of periods are most bothersome for women reporting heavy menstrual bleeding? Community survey and qualitative study. BMC Womens Health 2007 7 8
9. Fraser IS, Critchley HO, Munro MG, Broder M, Writing Group for this Menstrual Agreement Process. A process designed to lead to international agreement on terminologies and definitions used to describe abnormalities of menstrual bleeding. Fertil Steril 2007 87 3 466-476 (Pubitemid 46385988)
10. Rahn DD, Abed H, Sung VW et al. Systematic review highlights difficulty interpreting diverse clinical outcomes in abnormal uterine bleeding trials. J Clin Epidemiol 2011 64 3 293-300
11. Warner PE, Critchley HO, Lumsden MA, Campbell-Brown M, Douglas A, Murray GD. Menorrhagia II: is the 80-mL blood loss criterion useful in management of complaint of menorrhagia? Am J Obstet Gynecol 2004 190 5 1224-1229 (Pubitemid 38692201)
12. National Institute for Health and Clinical Excellence. Clinical Guideline 44; Heavy menstrual bleeding. Available at: http://www.nice.org.uk/nicemedia/ pdf/CG44FullGuideline.pdf Accessed May 23, 2011
13. Matteson KA, Clark MA. Questioning our questions: do frequently asked questions adequately cover the aspects of women's lives most affected by abnormal uterine bleeding? Opinions of women with abnormal uterine bleeding participating in focus group discussions. Women Health 2010 50 2 195-211
14. Lukes AS, Muse K, Richter HE, Moore KA, Patrick DL. Estimating a meaningful reduction in menstrual blood loss for women with heavy menstrual bleeding. Curr Med Res Opin 2010 26 11 2673-2678
15. Padilla LA, Radosevich DM, Milad MP. Limitations of the pelvic examination for evaluation of the female pelvic organs. Int J Gynaecol Obstet 2005 88 1 84-88 (Pubitemid 40023108)
16. Trasi SA, Pathare AV, Shetty SD, Ghosh K, Salvi V, Mohanty D. The spectrum of bleeding disorders in women with menorrhagia: a report from Western India. Ann Hematol 2005 84 5 339-342 (Pubitemid 41166829)
17. Saxena R, Gupta M, Gupta PK, Kashyap R, Choudhry VP, Bhargava M. Inherited bleeding disorders in Indian women with menorrhagia. Haemophilia 2003 9 2 193-196 (Pubitemid 36511656)
18. Kouides PA, Conard J, Peyvandi F, Lukes A, Kadir R. Hemostasis and menstruation: appropriate investigation for underlying disorders of hemostasis in women with excessive menstrual bleeding. Fertil Steril 2005 84 5 1345-1351 (Pubitemid 41571880)
19. Kadir RA, Chi C. Women and von Willebrand disease: controversies in diagnosis and management. Semin Thromb Hemost 2006 32 6 605-615 (Pubitemid 44453021)
20. James AH, Kouides PA, Abdul-Kadir R et al. Von Willebrand disease and other bleeding disorders in women: consensus on diagnosis and management from an international expert panel. Am J Obstet Gynecol 2009 201 1 12 e1-e8
21. Kadir RA, Economides DL, Sabin CA, Owens D, Lee CA. Frequency of inherited bleeding disorders in women with menorrhagia. Lancet 1998 351 9101 485-489 (Pubitemid 28070095)
22. Abu JI, Habiba MA, Baker R et al. Quantitative and qualitative assessment of women's experience of a one-stop menstrual clinic in comparison with traditional gynaecology clinics. BJOG 2001 108 9 993-999 (Pubitemid 32778597)
23. Vercellini P, Cortesi I, De Giorgi O, Merlo D, Carinelli SG, Crosignani PG. Transvaginal ultrasonography versus uterine needle biopsy in the diagnosis of diffuse adenomyosis. Hum Reprod 1998 13 10 2884-2887 (Pubitemid 28482746)
24. Farquhar C, Ekeroma A, Furness S, Arroll B. A systematic review of transvaginal ultrasonography, sonohysterography and hysteroscopy for the investigation of abnormal uterine bleeding in premenopausal women. Acta Obstet Gynecol Scand 2003 82 6 493-504 (Pubitemid 36750700)
25. Grimbizis GF, Tsolakidis D, Mikos T et al. A prospective comparison of transvaginal ultrasound, saline infusion sonohysterography, and diagnostic hysteroscopy in the evaluation of endometrial pathology. Fertil Steril 2010 94 7 2720-2725
26. Toth M, Patton DL, Esquenazi B, Shevchuk M, Thaler H, Divon M. Association between Chlamydia trachomatis and abnormal uterine bleeding. Am J Reprod Immunol 2007 57 5 361-366 (Pubitemid 46585361)
27. Baerwald AR, Pierson RA. Endometrial development in association with ovarian follicular waves during the menstrual cycle. Ultrasound Obstet Gynecol 2004 24 4 453-460 (Pubitemid 39185863)
28. Emanuel MH, Verdel MJ, Wamsteker K, Lammes FB. A prospective comparison of transvaginal ultrasonography and diagnostic hysteroscopy in the evaluation of patients with abnormal uterine bleeding: clinical implications. Am J Obstet Gynecol 1995 172 2 Pt 1 547-552
29. Schwärzler P, Concin H, Bösch H et al. An evaluation of sonohysterography and diagnostic hysteroscopy for the assessment of intrauterine pathology. Ultrasound Obstet Gynecol 1998 11 5 337-342 (Pubitemid 28282408)
30. Guido RS, Kanbour-Shakir A, Rulin MC, Christopherson WA. Pipelle endometrial sampling. Sensitivity in the detection of endometrial cancer. J Reprod Med 1995 40 8 553-555
31. Stovall TG, Ling FW, Morgan PL. A prospective, randomized comparison of the Pipelle endometrial sampling device with the Novak curette. Am J Obstet Gynecol 1991 165 5 Pt 1 1287-1290
32. Ben-Baruch G, Seidman DS, Schiff E, Moran O, Menczer J. Outpatient endometrial sampling with the Pipelle curette. Gynecol Obstet Invest 1994 37 4 260-262 (Pubitemid 24157029)
33. Dijkhuizen FP, Mol BW, Brölmann HA, Heintz AP. The accuracy of endometrial sampling in the diagnosis of patients with endometrial carcinoma and hyperplasia: a meta-analysis. Cancer 2000 89 8 1765-1772
34. Nilsson L, Rybo G. Treatment of menorrhagia. Am J Obstet Gynecol 1971 110 5 713-720
35. Grimes DA. Diagnostic dilation and curettage: a reappraisal. Am J Obstet Gynecol 1982 142 1 1-6 (Pubitemid 12209585)
36. Farquhar CM, Lethaby A, Sowter M, Verry J, Baranyai J. An evaluation of risk factors for endometrial hyperplasia in premenopausal women with abnormal menstrual bleeding. Am J Obstet Gynecol 1999 181 3 525-529 (Pubitemid 29453507)
37. Ash SJ, Farrell SA, Flowerdew G. Endometrial biopsy in DUB. J Reprod Med 1996 41 12 892-896 (Pubitemid 27020755)
38. Gibson M. Reproductive health and polycystic ovary syndrome. Am J Med 1995 98 1A 67S-75S
39. Morgan RW. Risk of endometrial cancer after tamoxifen treatment. Oncology (Williston Park) 1997 11 2, Suppl 1 25-33 (Pubitemid 27156078)
40. Lu KH, Dinh M, Kohlmann W et al. Gynecologic cancer as a sentinel cancer for women with hereditary nonpolyposis colorectal cancer syndrome. Obstet Gynecol 2005 105 3 569-574 (Pubitemid 40271224)
41. Fraser IS, Critchley HO, Munro MG. Abnormal uterine bleeding: getting our terminology straight. Curr Opin Obstet Gynecol 2007 19 6 591-595 (Pubitemid 350135444)
42. Vercellini P, Cortesi I, Oldani S, Moschetta M, De Giorgi O, Crosignani PG. The role of transvaginal ultrasonography and outpatient diagnostic hysteroscopy in the evaluation of patients with menorrhagia. Hum Reprod 1997 12 8 1768-1771 (Pubitemid 27406095)
43. Clark TJ. Outpatient hysteroscopy and ultrasonography in the management of endometrial disease. Curr Opin Obstet Gynecol 2004 16 4 305-311 (Pubitemid 41015801)
44. Dueholm M, Lundorf E, Hansen ES, Ledertoug S, Olesen F. Evaluation of the uterine cavity with magnetic resonance imaging, transvaginal sonography, hysterosonographic examination, and diagnostic hysteroscopy. Fertil Steril 2001 76 2 350-357 (Pubitemid 32703826)
45. Huang GS, Gebb JS, Einstein MH, Shahabi S, Novetsky AP, Goldberg GL. Accuracy of preoperative endometrial sampling for the detection of high-grade endometrial tumors. Am J Obstet Gynecol 2007 196 3 243 e1e5
46. Krampl E, Bourne T, Hurlen-Solbakken H, Istre O. Transvaginal ultrasonography sonohysterography and operative hysteroscopy for the evaluation of abnormal uterine bleeding. Acta Obstet Gynecol Scand 2001 80 7 616-622 (Pubitemid 32626058)
47. Ossola MW, Bertulessi C, Iasi L et al. Comparison of saline infusion sonography to transvaginal echography and hysteroscopy in the diagnostic evaluation of abnormal uterine bleeding. Int J Gynaecol Obstet 1999 11 145-150 (Pubitemid 30066101)
48. Munro MG, Brooks PG. Use of local anesthesia for office diagnostic and operative hysteroscopy. J Minim Invasive Gynecol 2010 17 6 709-718
49. Mohan S, Page LM, Higham JM. Diagnosis of abnormal uterine bleeding. Best Pract Res Clin Obstet Gynaecol 2007 21 6 891-903 (Pubitemid 350177602)
50. Marret H, Fauconnier A, Chabbert-Buffet N et al, CNGOF Collège National des Gynécologues et Obstétriciens Français. Clinical practice guidelines on menorrhagia: management of abnormal uterine bleeding before menopause. Eur J Obstet Gynecol Reprod Biol 2010 152 2 133-137
51. Chiang CH, Chang MY, Hsu JJ et al. Tumor vascular pattern and blood flow impedance in the differential diagnosis of leiomyoma and adenomyosis by color Doppler sonography. J Assist Reprod Genet 1999 16 5 268-275
52. Perrot N, Frey I, Mergui JL, Bazot M, Uzan M, Uzan S. Picture of the month. Adenomyosis: power Doppler findings. Ultrasound Obstet Gynecol 2001 17 2 177-178
53. Mark AS, Hricak H, Heinrichs LW et al. Adenomyosis and leiomyoma: differential diagnosis with MR imaging. Radiology 1987 163 2 527-529 (Pubitemid 17068939)
54. Bazot M, Cortez A, Darai E et al. Ultrasonography compared with magnetic resonance imaging for the diagnosis of adenomyosis: correlation with histopathology. Hum Reprod 2001 16 11 2427-2433 (Pubitemid 33054150)
55. Critchley HO, Warner P, Lee AJ, Brechin S, Guise J, Graham B. Evaluation of abnormal uterine bleeding: comparison of three outpatient procedures within cohorts defined by age and menopausal status. Health Technol Assess 2004 8 34 iii-iv 1-139
56. Burton KA, Henderson TA, Hillier SG et al. Local levonorgestrel regulation of androgen receptor and 17beta-hydroxysteroid dehydrogenase type 2 expression in human endometrium. Hum Reprod 2003 18 12 2610-2617 (Pubitemid 37536629)
57. Timan IS, Tatsumi N, Aulia D, Wangsasaputra E. Comparison of haemoglobinometry by WHO Haemoglobin Colour Scale and copper sulphate against haemiglobincyanide reference method. Clin Lab Haematol 2004 26 4 253-258 (Pubitemid 39070690)
58. Eisenberg JM, Williams SV, Garner L, Viale R, Smits H. Computer-based audit to detect and correct overutilization of laboratory tests. Med Care 1977 15 11 915-921 (Pubitemid 8237012)
59. Schroeder SA, Kenders K, Cooper JK, Piemme TE. Use of laboratory tests and pharmaceuticals. Variation among physicians and effect of cost audit on subsequent use. JAMA 1973 225 8 969-973
60. Dixon RH, Laszlo J. Ultilization of clinical chemistry services by medical house staff. An analysis. Arch Intern Med 1974 134 6 1064-1067
61. Schoenenberger RA, Tanasijevic MJ, Jha A, Bates DW. Appropriateness of antiepileptic drug level monitoring. JAMA 1995 274 20 1622-1626
62. Deeks JJ. Systematic reviews in health care: Systematic reviews of evaluations of diagnostic and screening tests. BMJ 2001 323 7305 157-162 (Pubitemid 32678396)
63. Lijmer JG, Mol BW, Heisterkamp S et al. Empirical evidence of design-related bias in studies of diagnostic tests. JAMA 1999 282 11 1061-1066 (Pubitemid 29436454)
64. van Dongen H, de Kroon CD, Jacobi CE, Trimbos JB, Jansen FW. Diagnostic hysteroscopy in abnormal uterine bleeding: a systematic review and meta-analysis. BJOG 2007 114 6 664-675 (Pubitemid 46788645)
65. Matteson KA, Boardman LA, Munro MG, Clark MA. Abnormal uterine bleeding: a review of patient-based outcome measures. Fertil Steril 2009 92 1 205-216
66. Hallberg L, Nilsson L. Determination of menstrual blood loss. Scand J Clin Lab Invest 1964 16 244-248
67. Hoppe-Seyler G, Broderson A, Rudolph A. Uber den Blutverlist bei der menstruation [in German]. Ztschr F Physiol Chem. 1904 42 545-553
68. Fraser IS, McCarron G, Markham R. A preliminary study of factors influencing perception of menstrual blood loss volume. Am J Obstet Gynecol 1984 149 7 788-793 (Pubitemid 14054212)
69. Magnay JL, Nevatte TM, Dhingra V, O'Brien S. Menstrual blood loss measurement: validation of the alkaline hematin technique for feminine hygiene products containing superabsorbent polymers. Fertil Steril 2010 94 7 2742-2746
70. Fraser IS, McCarron G, Markham R, Resta T. Blood and total fluid content of menstrual discharge. Obstet Gynecol 1985 65 2 194-198 (Pubitemid 15166979)
71. Fraser IS, Warner P, Marantos PA. Estimating menstrual blood loss in women with normal and excessive menstrual fluid volume. Obstet Gynecol 2001 98 5 Pt 1 806-814 (Pubitemid 33042549)
72. Reid PC. Assessment of menorrhagia by total menstrual fluid loss. J Obstet Gynaecol 2006 26 5 438-441
73. Higham JM, O'Brien PM, Shaw RW. Assessment of menstrual blood loss using a pictorial chart. Br J Obstet Gynaecol 1990 97 8 734-739 (Pubitemid 20263124)
74. Reid PC, Coker A, Coltart R. Assessment of menstrual blood loss using a pictorial chart: a validation study. BJOG 2000 107 3 320-322 (Pubitemid 30145371)